Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice.
Despite numerous evidences for neurotoxicity of overexpressed alpha-synuclein, a protective function was suggested for endogenous alpha-synuclein and other members of the synuclein family. This protective role is most important for and evident in presynaptic terminals, where synucleins are normally accumulated. However, mice lacking synucleins display no adverse phenotype. In particular, no significant changes in striatal dopamine metabolism and only subtle deficit of dopaminergic neurons in the substantia nigra were found in juvenile or adult mice. To assess whether aging and synuclein deficiency may have additive detrimental effect on the nigrostriatal system, we studied dopaminergic neurons of the substantia nigra and their striatal synapses in 24-26-month-old alpha-synuclein and gamma-synuclein null mutant mice. Significant approximately 36% reduction of the striatal dopamine was found in aging alpha-synuclein, but not gamma-synuclein null mutant mice when compared to age-matching wild type mice. This was accompanied by the reduction of TH-positive fibers in the striatum and decrease of striatal levels of TH and DAT. However, no progressive loss of TH-positive neurons was revealed in the substantia nigra of synuclein-deficient aging animals. Our results are consistent with a hypothesis that alpha-synuclein is important for normal function and integrity of synapses, and suggest that in the aging nervous system dysfunction of this protein could become a predisposition factor for the development of nigrostriatal pathology.
Al-Wandi
Abdelmojib
A
School of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3US, United Kingdom.
Ninkina
Natalia
N
Millership
Steven
S
Williamson
Sally J M
SJ
Jones
Paul A
PA
Buchman
Vladimir L
VL
D000367:Age Factors; D000375:Aging / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D015153:Blotting, Western; D002452:Cell Count; D002851:Chromatography, High Pressure Liquid; D003342:Corpus Striatum / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D007150:Immunohistochemistry; D051379:Mice; D018345:Mice, Knockout; D009412:Nerve Fibers / Q000378:metabolism; D009474:Neurons / Q000378:metabolism; D013378:Substantia Nigra / Q000378:metabolism*; D013569:Synapses / Q000235:genetics / Q000378:metabolism*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism; D051844:alpha-Synuclein / Q000235:genetics / Q000378:metabolism*; D051845:gamma-Synuclein / Q000235:genetics / Q000378:metabolism
D051844:alpha-Synuclein; D051845:gamma-Synuclein; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine